We analyzed CDKN2A expression across various tissue samples, including normal, adjacent, and tumor tissues, as well as normal intestinal epithelial cells (NCM460) and multiple CRC cell lines (HT29, HCT116, SW620, SW480). Here, CDKN2A is linked to neoplasm.